予防ヘルスケア技術・サービスの世界市場：サービスタイプ別、技術タイプ別、エンドユーザー別、地域別

世界の予防ヘルスケア技術・サービス市場は、2024年には2,752億9,000万米ドルとなり、2024～2031年にかけてCAGR10.6％を示し、2031年には5,566億4,000万米ドルに達すると予測されます。

図.予防ヘルスケア技術・サービスの世界市場シェア（%）、地域別、2024年

予防ヘルスケア技術・サービスの世界市場は、近年著しい成長を遂げています。予防ヘルスケアは、病気や症状、怪我を予防し、健康を促進することを目的としています。技術の進歩と集団健康管理への関心の高まりにより、予防医療の範囲は拡大しています。画像診断、先進バイオマーカー、遺伝学など様々な技術により、疾病の早期発見とリスク評価が可能になりました。また、デジタルヘルスソリューションの普及により、遠隔モニタリングがサポートされ、予防サービスへのアクセスが容易になっています。世界中で慢性疾患の有病率が上昇するにつれ、予防的介入に対する需要は飛躍的に高まっています。このため、革新的な予防ヘルスケアモデルや対策の開発への投資が促されています。予防への注目度が高まるにつれ、市場は今後数年間で大きく成長すると予想されます。

市場力学：

生活習慣病の罹患率の上昇、慢性疾患に罹患しやすい高齢者人口の増加、治療に伴う医療費の増加が、予防ヘルスケア技術・サービスの需要を促進しています。また、国民の健康を目的としたさまざまな政府プログラムも、こうしたソリューションの採用を後押ししています。しかし、先進的な予防医療技術やサービスの展開には多額の投資が必要であることが足かせとなっています。手ごろな価格の予防ソリューションを開拓することは、市場開拓者にとってチャンスです。人工知能などの最先端技術を統合することも、予防医療に革命をもたらす可能性を秘めています。

本調査の主な特徴

• 当レポートでは、世界の予防ヘルスケア技術・サービス市場を詳細に分析し、2023年を基準年とした予測期間（2024～2031年）の市場規模と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 世界の予防ヘルスケア技術・サービス市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。
• 主要企業には、Healthlane、Abbott、GSK plc、Myriad Genetics、Omron Healthcare Inc.、Quest Diagnostics、Pfizer, Inc.、Merck &Co., Inc.、Omnicell、Novx Systems, Corp.、U-Systems, Ltd.、Viatronix, Inc.、Scripto LLC、Lifecom, Inc.、Dilon Medical Technologies, Inc.、McKesson Corporationなどがあります。
• 本レポートから得られる洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができるようになります。
• 世界の予防ヘルスケア技術・サービス市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の予防ヘルスケア技術・サービス市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 製品の発売/承認
• ブランドと価格分析
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の予防ヘルスケア技術・サービス市場 - コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の予防ヘルスケア技術・サービス市場、サービスタイプ別、2019～2031年

• 診断サービス
• ウェルネス・健康評価サービス
• 遠隔医療サービス
• 薬局サービス
• その他

第6章 世界の予防ヘルスケア技術・サービス市場、技術タイプ別、2019～2031年

• 遠隔医療
• mヘルス
• 医療情報技術
• ウェアラブルデバイス
• その他

第7章 世界の予防ヘルスケア技術・サービス市場、エンドユーザー別、2019～2031年

• ヘルスケア提供者
• ヘルスケア支払者
• その他

第8章 世界の予防ヘルスケア技術・サービス市場、地域別、2019～2031年

第9章 競合情勢

• 企業プロファイル
  • Healthlane
  • Abbott
  • GSK plc
  • Myriad Genetics
  • Omron Healthcare Inc.
  • Quest Diagnostics
  • Pfizer, Inc.
  • Merck &Co., Inc.
  • Omnicell
  • Novx Systems, Corp.
  • U-Systems, Ltd.
  • Viatronix, Inc.
  • Scripto LLC
  • Lifecom, Inc.
  • Dilon Medical Technologies, Inc.
  • McKesson Corporation

第10章 アナリストの視点

• 運命の輪
• アナリストの見解
• Coherent Opportunity Map

第11章 参考文献と調査手法

• 参考文献
• 調査手法

The global preventive healthcare technologies and services market is estimated to be valued at USD 275.29 Bn in 2024 and is expected to reach USD 556.64 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031.

Figure. Global Preventive Healthcare Technologies And Services Market Share (%), By Region 2024

The global preventive healthcare technologies and services market has been witnessing significant growth in recent years. Preventive healthcare aims to prevent diseases, conditions or injuries and promote good health. Advancements in technologies and growing focus on population health management have expanded the scope of preventive care. Various technologies such as imaging, advanced biomarkers, and genetics have enabled early detection and risk assessment of diseases. In addition, the widespread adoption of digital health solutions is supporting remote monitoring and facilitating access to preventive services. As the prevalence of chronic diseases rises worldwide, the demand for preventive interventions is growing exponentially. This has prompted investments into the development of innovative preventive healthcare models and measures. The market is expected to grow substantially in the coming years as focus on prevention gains more prominence.

Market Dynamics:

Rising incidence of lifestyle diseases, growing geriatric population susceptible to chronic illnesses and increasing healthcare costs associated with treatment are driving the demand for preventive healthcare technologies and services. Various government programmes aimed at population health are also boosting the adoption of these solutions. However, high investment requirements for the deployment of advanced preventive technologies and services act as a restraint. Developing affordable preventive solutions represents an opportunity for market players. Integrating cutting-edge technologies, such as artificial intelligence, also holds potential to revolutionize preventive care.

Key Features of the Study:

• This report provides an in-depth analysis of the global preventive healthcare technologies and services market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global preventive healthcare technologies and services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Healthlane, Abbott , GSK plc, Myriad Genetics, Omron Healthcare Inc., Quest Diagnostics, Pfizer, Inc., Merck & Co., Inc., Omnicell , Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., Scripto LLC , Lifecom, Inc., Dilon Medical Technologies, Inc., and McKesson Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global preventive healthcare technologies and services market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive healthcare technologies and services market.

Detailed Segmentation-

• By Service Type:
  • Diagnostic Services
  • Wellness & Health Assessment Services
  • Telemedicine Services
  • Pharmacy Services
  • Others
• By Technology Type:
  • Telemedicine
  • mHealth
  • Health Information Technology
  • Wearable Devices
  • Others
• By End User:
  • Healthcare Providers
  • Healthcare Payers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Healthlane
  • Abbott
  • GSK plc
  • Myriad Genetics
  • Omron Healthcare Inc.
  • Quest Diagnostics
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Omnicell
  • Novx Systems, Corp.
  • U-Systems, Ltd.
  • Viatronix, Inc.
  • Scripto LLC
  • Lifecom, Inc.
  • Dilon Medical Technologies, Inc.
  • McKesson Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Service Type
  • Market Snapshot, By Technology Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Brand and Pricing Analysis
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Preventive Healthcare Technologies And Services Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Preventive Healthcare Technologies And Services Market, By Service Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Diagnostic Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Wellness & Health Assessment Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Telemedicine Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Pharmacy Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Preventive Healthcare Technologies And Services Market, By Technology Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Telemedicine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• mHealth
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Health Information Technology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Wearable Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Preventive Healthcare Technologies And Services Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Healthcare Providers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Healthcare Payers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Preventive Healthcare Technologies And Services Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Healthlane
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
  • GSK plc
  • Myriad Genetics
  • Omron Healthcare Inc.
  • Quest Diagnostics
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Omnicell
  • Novx Systems, Corp.
  • U-Systems, Ltd.
  • Viatronix, Inc.
  • Scripto LLC
  • Lifecom, Inc.
  • Dilon Medical Technologies, Inc.
  • McKesson Corporation

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact